Intranasal epinephrine in dogs: Pharmacokinetic and heart rate effects.


Journal

Pharmacology research & perspectives
ISSN: 2052-1707
Titre abrégé: Pharmacol Res Perspect
Pays: United States
ID NLM: 101626369

Informations de publication

Date de publication:
04 2020
Historique:
received: 24 02 2020
revised: 09 03 2020
accepted: 11 03 2020
entrez: 18 4 2020
pubmed: 18 4 2020
medline: 7 4 2021
Statut: ppublish

Résumé

Epinephrine is the standard of care for the treatment of severe allergy and anaphylaxis. Epinephrine is most often administered through the intramuscular (IM) route via autoinjector. The current study aimed to evaluate an alternative method of epinephrine treatment through intranasal (IN) delivery in dogs. The pharmacokinetic (PK) parameters of maximum plasma concentration (C

Identifiants

pubmed: 32302068
doi: 10.1002/prp2.587
pmc: PMC7164403
doi:

Substances chimiques

Bronchodilator Agents 0
Epinephrine YKH834O4BH

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00587

Informations de copyright

© 2020 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.

Références

J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1143-1146
pubmed: 27283056
Allergy Asthma Proc. 2014 May-Jun;35(3):195-6
pubmed: 24801460
J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2252-2261
pubmed: 30922991
Pediatrics. 2017 Mar;139(3):
pubmed: 28193791
West J Emerg Med. 2018 Jul;19(4):693-700
pubmed: 30013706
World Allergy Organ J. 2015 Oct 28;8(1):32
pubmed: 26525001
Am J Health Syst Pharm. 2014 Dec 15;71(24):2129-35
pubmed: 25465584
Circulation. 2018 May 8;137(19):2032-2040
pubmed: 29511001
Am J Health Syst Pharm. 2015 Sep 15;72(18):1544-54
pubmed: 26346210
J Allergy Clin Immunol. 2001 Nov;108(5):871-3
pubmed: 11692118
Pediatrics. 2000 Feb;105(2):359-62
pubmed: 10654956
J Emerg Med. 2017 Jul;53(1):38-48
pubmed: 28259526
Addiction. 2009 Dec;104(12):2067-74
pubmed: 19922572
J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1169-1178
pubmed: 28888247
Ann Allergy Asthma Immunol. 2009 Apr;102(4):282-7
pubmed: 19441598
JAMA Netw Open. 2018 Nov 2;1(7):e184728
pubmed: 30646369
Ann Emerg Med. 2016 Mar;67(3):307-315.e8
pubmed: 26452720
J Manag Care Spec Pharm. 2016 Dec;22(12):1426-1436
pubmed: 27882840
Acta Pharm Nord. 1990;2(2):105-22
pubmed: 2191690
Addict Behav. 2018 Nov;86:86-89
pubmed: 29914719
J Pharmacol Exp Ther. 2019 Nov;371(2):409-415
pubmed: 30940694
Diabetes Care. 2016 Feb;39(2):264-70
pubmed: 26681725
CMAJ. 2015 Dec 8;187(18):E509-E510
pubmed: 26553857
Addiction. 2018 Mar;113(3):484-493
pubmed: 29143400
J Allergy Clin Immunol. 2014 Feb;133(2):461-7
pubmed: 24144575
Brain Res Bull. 2018 Oct;143:155-170
pubmed: 30449731
Ann Allergy Asthma Immunol. 2015 Nov;115(5):341-84
pubmed: 26505932
J Food Drug Anal. 2015 Dec;23(4):595-608
pubmed: 28911475
J Pharm Pharm Sci. 2009;12(3):288-311
pubmed: 20067706
Ann Allergy Asthma Immunol. 2013 Aug;111(2):132-7
pubmed: 23886232
Pharmaceutics. 2019 Mar 11;11(3):
pubmed: 30861990
Ann Emerg Med. 1992 Sep;21(9):1125-30
pubmed: 1514727
Ann Emerg Med. 2006 Apr;47(4):373-80
pubmed: 16546624
Am J Emerg Med. 1996 Mar;14(2):133-8
pubmed: 8924133
Epilepsy Behav. 2017 Jun;71(Pt A):51-59
pubmed: 28544992
Int Forum Allergy Rhinol. 2017 Mar;7(3):276-286
pubmed: 27869359
Asian Pac J Allergy Immunol. 2016 Mar;34(1):38-43
pubmed: 26994624
Allergy. 2005 Feb;60(2):259-60
pubmed: 15647051
Drug Healthc Patient Saf. 2017 Mar 21;9:9-18
pubmed: 28356773
Ann Allergy Asthma Immunol. 2017 Aug;119(2):108-110
pubmed: 28676208

Auteurs

Kenneth L Dretchen (KL)

Mesa Science Associates, Inc., Frederick, MD, USA.

Zack Mesa (Z)

Mesa Science Associates, Inc., Frederick, MD, USA.

Matthew Robben (M)

Robben Consulting, LLC, Rochester, NY, USA.

Desmond Slade (D)

MRIGlobal, Kansas City, MO, USA.

Scott Hill (S)

MRIGlobal, Kansas City, MO, USA.

Claire Croutch (C)

MRIGlobal, Kansas City, MO, USA.

Kyle Kappeler (K)

Citoxlab, Stilwell, KS, USA.

Michael Mesa (M)

Mesa Science Associates, Inc., Frederick, MD, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH